NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹258 Cr | ₹218 Cr | ₹199 Cr | ₹150 Cr | ₹9,494,069 Cr |
What is the latest Appropriations of NGL FINECHEM ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹218 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹150 Cr |
| Mar2021 | ₹9,494,069 Cr |
How is Appropriations of NGL FINECHEM Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 18.36 | |
| Mar2024 | ₹218 Cr | 9.71 | |
| Mar2023 | ₹199 Cr | 32.45 | |
| Mar2022 | ₹150 Cr | -100.00 | |
| Mar2021 | ₹9,494,069 Cr | - | |
Compare Appropriations of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,752.8 Cr | 17.1% | 26.6% | 119.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 17.1% |
26.6% |
119.2% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses